Emergence of blaGES-5 in clinical colistin-onlysensitive (COS) Pseudomonas aeruginosa strain in Brazil [3]

Journal of Antimicrobial Chemotherapy

Volumn 59, Issue 3, 2007, Pages 576-577

  da Fonseca, Érica Lourenço ^a   Vieira, Verônica Viana ^b   Cipriano, Rosângela ^a,c   Vicente, Ana Carolina Paulo ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b Oswaldo Cruz Foundation   (Brazil)

^c FEDERAL UNIVERSITY OF MARANHÃO   (Brazil)

Author keywords

Brazilian clinical setting; Class 1 integrons; Gene cassette evolution; P. aeruginosa

Indexed keywords

AZTREONAM; BETA LACTAMASE; BETA LACTAMASE GES 5; CEFEPIME; CEFTAZIDIME; COLISTIN; IMIPENEM; METALLO BETA LACTAMASE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; GES 1 BETA LACTAMASE; GES-1 BETA-LACTAMASE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; BRAZIL; GENE CASSETTE; GENE EXPRESSION REGULATION; GENE SEQUENCE; HOSPITAL INFECTION; INTEGRON; KLEBSIELLA PNEUMONIAE; LETTER; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; POINT MUTATION; POLYMERASE CHAIN REACTION; PROMOTER REGION; PSEUDOMONAS AERUGINOSA; SEQUENCE ANALYSIS; DRUG EFFECT; ENZYMOLOGY; GENETICS; HUMAN; MICROBIOLOGICAL EXAMINATION; MOLECULAR GENETICS;

ANTI-BACTERIAL AGENTS; BASE SEQUENCE; BETA-LACTAMASES; COLISTIN; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR SEQUENCE DATA; PSEUDOMONAS AERUGINOSA;

EID: 34248214149     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl517     Document Type: Letter

References (7)

1. Wang C, Cai P, Chang D, Mi Z. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum β-lactamase. J Antimicrob Chemother 2006; 57: 1261-2.
2. Vourli S, Giakkoupi P, Miriagou V et al. Novel GES/IBC extended-spectrum β-lactamase variants with carbapenemase activity in clinical enterobacteria. FEMS Microbiol Lett 2004; 234: 209-13.
3. Jeong SH, Bae IK, Kim D et al. First outbreak of Klebsiella pneumoniae clinical isolates producing GES-5 and SHV-12 extended-spectrum β-lactamases in Korea. Antimicrob Agents Chemother 2005; 49: 4809-10.
4. Falagas ME, Kasiakou SK. Correct use of the term 'pan-drug-resistant' (PDR) Gram-negative bacteria. Clin Microbiol Infect 2005; 12 1049-50.
5. Collis CM, Hall RM. Expression of antibiotic resistance genes in the integrated cassettes of integrons. Antimicrob Agents Chemother 1995; 39: 155-62.
6. GES-1 and a fused product of aac(3)-lb/aac(6″)-1b″ gene cassettes in Pseudomonas aeruginasa. Antimicrob Agents Chemother 2002; 46: 638-45.
7. Poirel L, Le Thomas I. Naas T et al. Biochemical sequence analyses of GES-1, a novel class A extended-spectrum β-lactamase, and the class 1 integron ln52 from Klebsiella pneumoniae. Antimicrob Agents Chemother 2000; 44: 622-32.